Searched for
AI IN CANCER RESEARCH
These large-, mid- and small-cap stocks have upside potential of up to 32% in 1 year, according to analystsThe market has risen these past weeks partly because money was leaving the AI trade and looking for a new home. The real test comes now, if...
Bengaluru researcher gets Google Phd Fellowship to study why some patients with cancer experience recurrenceBengaluru-based NCBS researcher Surya Sarathi Das has received the 2026 Google PhD Fellowship to develop AI models that could help predict ...
India needs affordable access alongside pharma innovation, experts say at OPPI summitIndia's pharmaceutical sector is facing challenges in balancing innovation with affordable access to treatments. Experts believe that stron...
Lucknow sweet seller's son earns Rs 2.5 crore annual salary after scoring just 48% in class 5; heads an AI company in Dubai nowTejesh Vaish, a 26-year-old from Lucknow, scored 48% in Class 5 before improving his academic performance, securing admission to IIT Kanpur...
Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 28% in 1 year, according to analystsIt is not time yet to abandon the discipline that got you through the bad patch which the market has seen in the last over two years. So, g...
These large-, mid- and small-cap stocks have upside potential of more than 20% in 1 year, according to analystsThe probability of a sharp, damaging downturn now appears low, and the broad direction favours the market. So, the stance should be the sam...
Dario Amodei says AI could make cancer, Alzheimer’s ‘relics of the past’ in less than a decade as Anthropic expands AI-driven drug discovery pushAnthropic is collaborating with several pharmaceutical companies to utilize AI in drug development processes. These partnerships aim to imp...
Ode to a compassionate algorithm: Philanthropists are backing AI for public goodFrom Flipkart’s Binny Bansal to Chrys Capital’s Ashish Dhawan and Karishma Sanghvi of Sun Pharma, a growing number of entrepreneurs are wri...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28% in 1 year, according to analystsDespite the upbeat mood in the market, remember one thing: Valuations are still not cheap. Even after everything the market has been throug...
These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analystsIn the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attent...
The man behind Lord’s Mark: Dr. Sachidanand Upadhyay features in TIME Magazine for the third consecutive yearDr. Sachidanand Upadhyay has gained recognition from TIME Magazine for his remarkable contributions to technology and innovation. Lord’s Ma...
His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccinesHyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technol...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%Oil prices matter to the Indian economy, and the market responded with a smart rally as Brent crude cooled significantly on Monday. The ral...
Can a simple selfie reveal clues about cancer? New study finds surprising answers in patients’ facesA photograph may contain health clues that are difficult to measure at a glance. Researchers have developed AI tools that connect facial fe...
German startup NVision shows new path to quantum computing chips in Nature paperStartups and tech giants such as Microsoft and IBM alike are racing to build quantum computers that hold the promise of solving problems th...
Oracle's Larry Ellison dismisses 'SaaS apocalypse' fears, says AI will make software betterSpeaking at Oracle AI World here, Ellison, the company's executive chairman and chief technology officer, rejected talk of a "SaaS apocalyp...
Practo founder’s Cent raises $15 million from Blume Ventures, South Park CommonsThe round, comprising equity and debt, comes nearly eight months after the Bengaluru-based company raised an undisclosed amount from South ...
Pathos AI teams up with Bristol Myers and Tempus AI to advance drug developmentPathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence too...
Shridevi Institute, US-based Vaxonyx sign MoU for AI-driven cancer and genomic researchShridevi Institute of Medical Sciences in Tumakuru has signed an MoU with Vaxonyx LLC for collaboration. This partnership aims to focus on ...
AI researchers are smoking to demonstrate their belief that it will beat cancer: Palantir CTO Shyam SankarShyam Sankar, CTO of Palantir Technologies, highlighted AI researchers' intense commitments, likening it to social delusion. He pointed out...